Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The return on invested capital (ROIC) is N/A as of the fiscal period ended Wednesday, December 31, 2025.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q4 FY2025 (2025-12-31): -320.89%.
RETURN ON INVESTED CAPITAL (ROIC)
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-357.73%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-394.37%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-414.26%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Ensysce Biosciences, Inc.
Market Cap
$6.44M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-357.73%
3Y Avg
-394.37%
5Y Avg
-414.26%
Market Cap
$6.34M
Return on Invested Capital (ROIC)
-117.93%
TTM Avg
-116.75%
3Y Avg
-95.39%
5Y Avg
-83.55%
Market Cap
$6.72M
Return on Invested Capital (ROIC)
-90.17%
TTM Avg
-79.44%
3Y Avg
-64.42%
5Y Avg
-71.54%
Market Cap
$6.74M
Return on Invested Capital (ROIC)
-57.11%
TTM Avg
-311.64%
3Y Avg
-524.77%
5Y Avg
-524.77%
Market Cap
$6.76M
Return on Invested Capital (ROIC)
-107.99%
TTM Avg
-407.39%
3Y Avg
-445.97%
5Y Avg
-342.27%
Market Cap
$6.10M
Return on Invested Capital (ROIC)
-209.05%
TTM Avg
-147.42%
3Y Avg
-107.09%
5Y Avg
-98.13%
Market Cap
$6.10M
Return on Invested Capital (ROIC)
-82.84%
TTM Avg
-84.28%
3Y Avg
-109.54%
5Y Avg
-250.89%
Market Cap
$6.09M
Return on Invested Capital (ROIC)
-0.32%
TTM Avg
-32.77%
3Y Avg
-50.72%
5Y Avg
-41.90%
Market Cap
$6.03M
Return on Invested Capital (ROIC)
-84.15%
TTM Avg
-84.15%
3Y Avg
-84.15%
5Y Avg
-84.15%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Ensysce Biosciences, Inc. (ENSC) | $6.44M | N/A | -357.73% | -394.37% | -414.26% |
| Biomerica, Inc. (BMRA)vs › | $6.34M | -117.93% | -116.75% | -95.39% | -83.55% |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.72M | -90.17% | -79.44% | -64.42% | -71.54% |
| Aclarion, Inc. (ACON)vs › | $6.74M | -57.11% | -311.64% | -524.77% | -524.77% |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.76M | -107.99% | -407.39% | -445.97% | -342.27% |
| Femasys Inc. (FEMY)vs › | $6.10M | -209.05% | -147.42% | -107.09% | -98.13% |
| Cardio Diagnostics Holdings, Inc. (CDIO)vs › | $6.10M | -82.84% | -84.28% | -109.54% | -250.89% |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $6.09M | -0.32% | -32.77% | -50.72% | -41.90% |
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs › | $6.03M | -84.15% | -84.15% | -84.15% | -84.15% |
| Co-Diagnostics, Inc. (CODX)vs › | $6.88M | -219.15% | -109.13% | -72.14% | -33.59% |
ROIC
N/A
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-12-31 | -320.89% |
| 2025-09-30 | -874.14% |
| 2025-06-30 | -190.76% |
| 2025-03-31 | -220.54% |
| 2024-12-31 | -182.30% |
| 2024-09-30 | -90.52% |
| 2024-06-30 | -497.12% |
| 2024-03-31 | -271.44% |
| 2023-12-31 | -4663.77% |
| 2023-09-30 | -894.25% |
| 2023-06-30 | -401.73% |
| 2022-12-31 | -3523.46% |
| 2022-09-30 | -504.73% |
| 2022-06-30 | -1385.16% |
| 2022-03-31 | -250.02% |
| 2021-12-31 | -156.34% |
| 2021-09-30 | -344.98% |
| 2021-06-30 | -43.22% |
| 2020-09-30 | -19.08% |
| 2020-06-30 | -20.83% |
| 2020-03-31 | -5.84% |
| 2019-12-31 | -0.94% |
| 2019-09-30 | -0.82% |
| 2019-06-30 | -0.67% |
| 2019-03-31 | -0.58% |
| 2018-12-31 | -0.60% |
| 2018-09-30 | -0.36% |
| 2018-06-30 | -0.27% |
